In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD). Memantine is an uncompetitive N-methyl-D-aspartate ...

Nystagmus is characterized by involuntary to and fro movement of the eyes. There is evidence to indicate that memantine and gabapentin can reduce acquired nystagmus, but these drugs have not been ...

Memantine HCl 7mg, 14mg, 21mg, 28mg; ext-rel caps. Tabs—60; Titration Pak (28 x 5mg + 21 x 10mg)—1; Oral soln—contact supplier; XR caps 7mg, 21mg—30; 14mg, 28mg—30, 90; XR Titration Pak ...

Alzheimerrsquo;s disease is a condition that leads to the deterioration of brain cells Read on to learn about its treatment ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

ALPHA-1062 is also being developed for use along with memantine for moderate to severe Alzheimer’s dementia and as an intranasal dose to treat cognitive impairment linked to mTBI. "FDA accepts ...

They tried memantine and Aricept, drugs for moderate to severe Alzheimer’s that can help with confusion and memory loss. Neither drug helped, and the side effects were intolerable. Today ...

Alzheimer’s is the most common type of dementia. Medications used for Alzheimer’s disease include cholinesterase inhibitors and memantine (Namenda). Cholinesterase inhibitors boost the levels ...

“Such meds have been known to help 40% of patients slow the decline for six months or so,” Landsverk notes. Memantine (Namenda), which works by regulating glutamate, a chemical messenger in the brain ...

Drugs like memantine (Namenda) and piracetam have shown some success in small studies. But more research needs to be done before they can be recommended for treatment. Group therapy. This can be ...

Medications such as cholinesterase inhibitors (e.g. galantamine) or NMDA antagonists (e.g. memantine) can help with symptoms. Behavioral treatments can address anxiety, depression, irritability ...

Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe ...